Last reviewed · How we verify
NCT05836181: EMDR
The Effect of Eye Movement Desensitization and Reprocessing Intervention in Hypertension Patient.
NA trial testing Eye Movement Desensitization and Reprocessing in Eye Movement Desensitization and Reprocessing Intervention in 110 participants. Completed in 28 December 2016.
10 December 2016
Quick facts
| Lead sponsor | Miao-Yi Chen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 110 |
| Start date | 1 February 2014 |
| Primary completion | 10 December 2016 |
| Estimated completion | 28 December 2016 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Eye Movement Desensitization and Reprocessing
Conditions studied
- Eye Movement Desensitization and Reprocessing Intervention — all drugs for Eye Movement Desensitization and Reprocessing Intervention →
- Blood Pressure — all drugs for Blood Pressure →
- Heart Rate Variability — all drugs for Heart Rate Variability →
- Anxiety — all drugs for Anxiety →
Sponsor
Miao-Yi Chen
Who can join
Adults 20 to 80, any sex, with Eye Movement Desensitization and Reprocessing Intervention or Blood Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Eye Movement Desensitization and Reprocessing intervention may improve anxiety, depression, systolic blood pressure and heart rate variability in patients with hypertension.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05836181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Eye Movement Desensitization and Reprocessing
Trials testing the same drug.
- NCT06171230 — Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment for Chronic Painful Diabetic Peripheral Neuropathy · NA · unknown
- NCT04472988 — Eye Movement Desensitization and Reprocessing on Autoimmune Thyroiditis in Adults · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05836181 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Miao-Yi Chen
- Last refreshed: 1 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05836181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing